Metal–semiconductor junction

Compression Works Announces Scott Garrett as Chief Operating Officer

Retrieved on: 
Thursday, July 14, 2022

BIRMINGHAM, Ala., July 14, 2022 /PRNewswire-PRWeb/ -- Compression Works Inc., the medical device company that created the Abdominal Aortic and Junctional Tourniquet – Stabilized (AAJT-S) for the treatment of non-compressible hemorrhages in the global EMS and military markets, welcomes Scott Garrett as its new Chief Operating Officer. In his new role, Mr. Garrett will be responsible for driving company growth, scaling operations to meet the increasing global demand for the AAJT-S device and increasing sales in the global EMS, first responder, tactical law enforcement and military markets.

Key Points: 
  • Compression Works Inc., the medical device company that created the Abdominal Aortic and Junctional Tourniquet Stabilized (AAJT-S) for the treatment of non-compressible hemorrhages in the global EMS and military markets, welcomes Scott Garrett as its new Chief Operating Officer.
  • BIRMINGHAM, Ala., July 14, 2022 /PRNewswire-PRWeb/ -- Compression Works Inc., the medical device company that created the Abdominal Aortic and Junctional Tourniquet Stabilized (AAJT-S) for the treatment of non-compressible hemorrhages in the global EMS and military markets, welcomes Scott Garrett as its new Chief Operating Officer.
  • "We are absolutely thrilled to have Scott Garrett join our executive team," stated President and CEO of Compression Works, Scott Dodson.
  • The Compression Works technology stops the most difficult bleeding conditions so the patient can be stabilized and taken to definitive care," said Garrett.

Comprehensive Scientific Study Demonstrates Compression Works' AAJT-S Device Useful in Traumatic Cardiac Arrest and Non-Compressible Truncal Hemorrhage Patients

Retrieved on: 
Tuesday, May 3, 2022

BIRMINGHAM, Ala., May 3, 2022 /PRNewswire-PRWeb/ -- Compression Works, creators of the Abdominal Aortic and Junctional Tourniquet-Stabilized (AAJT-S) device, announces the publication of a new trauma review article in the Annals of Emergency Medicine, "External Aortic Compression in Noncompressible Truncal Hemorrhage and Traumatic Cardiac Arrest: A Scoping Review." The study examines aortic compression as it relates to non-compressible truncal hemorrhage and traumatic cardiac arrest subjects.

Key Points: 
  • A new trauma review article in the Annals of Emergency Medicine examines aortic compression as it relates to non-compressible truncal hemorrhage and traumatic cardiac arrest subjects.
  • The study examines aortic compression as it relates to non-compressible truncal hemorrhage and traumatic cardiac arrest subjects.
  • The AAJT-S device by Compression Works is currently FDA cleared to treat non-compressible hemorrhages in the axilla, abdomen and groin region.
  • "With over 70 scientific studies published about the Compression Works' life-saving device, the AAJT-S is the most studied device in its class.

Compression Works Rushing Unique Life-Saving Tourniquets to Ukraine

Retrieved on: 
Monday, April 4, 2022

BIRMINGHAM, Ala., April 4, 2022 /PRNewswire-PRWeb/ -- Compression Works, Inc. maker of the Abdominal Aortic and Junctional Tourniquet-Stabilized (AAJT-S) device, announces a relief effort to support the people of Ukraine with its life-saving hemorrhage control solution. The AAJT-S devices are intended to help warfighters and civilians who have been injured as a result of the Russia invasion.

Key Points: 
  • BIRMINGHAM, Ala., April 4, 2022 /PRNewswire-PRWeb/ -- Compression Works, Inc. maker of the Abdominal Aortic and Junctional Tourniquet-Stabilized (AAJT-S) device, announces a relief effort to support the people of Ukraine with its life-saving hemorrhage control solution.
  • The Compression Works device is designed to stop traumatic bleeding resulting from non-compressible hemorrhages.
  • "I am grateful for the support of Compression Works to help the freedom fighters and citizens of Ukraine who are being injured in this struggle," continued Danchak.
  • Compression Works is a veteran owned business dedicated to saving lives on and off the battlefield.

New Vishay Intertechnology 650 V SiC Schottky Diodes Increase Efficiency for High Frequency Applications

Retrieved on: 
Monday, January 25, 2021

MALVERN, Pa., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today introduced 10 new 650 V silicon carbide (SiC) Schottky diodes .

Key Points: 
  • MALVERN, Pa., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today introduced 10 new 650 V silicon carbide (SiC) Schottky diodes .
  • Featuring a merged PIN Schottky (MPS) design, the Vishay Semiconductors devices are designed to increase the efficiency of high frequency applications by reducing switching losses regardless of the effects from temperature variances, allowing the diodes to operate at higher temperatures.
  • The MPS design of the diodes released today shields the electric field from the Schottky barrier to reduce leakage currents while increasing surge current capability via hole injection.
  • Compared to pure silicon Schottky devices, the diodes handle the same level of current with only a slight increase in forward voltage drop while demonstrating a significantly higher degree of ruggedness.